Abstracts tagged "Activity score"

Abstract Number: 2490 • 2016 ACR/ARHP Annual Meeting
Impact of Obesity Activity Indices and Therapeutic Dosage in Patients with Rheumatoid Arthritis in Dominican Republic
E Rodríguez-Bautista¹, V Rosario¹, R Peña-Blanco², R Munoz-Louis¹, Y Cruz-Rojas¹, I Paulino-Izquierdo¹, J Paula-Mateo¹, T Valdez-Lorie² and R Alba-Fériz¹, ¹Rheumatology, Hospital Docente Padre Billini (HDPB), Santo Domingo, Dominican Republic, ²Rheumatology, Hospital Docente Universitario Dr. Francisco E. Moscoso Puello (HFMP), Santo Domingo, Dominican Republic
Background/Purpose: Rheumatoid arthritis (RA) is an autoimmune disease characterized by chronic arthritis that mainly affects small and medium joints. It is the most common form…
Abstract Number: 2935 • 2016 ACR/ARHP Annual Meeting
Activation Status of Mucosal-Associated Invariant T Cells Sensitively Reflects Disease Activity of Systemic Lupus Erythematosus
Asako Chiba¹, Goh Murayama², Mie Kitagaichi³, Naoto Tamura⁴, Ken Yamaji², Yoshinari Takasaki⁴ and Sachiko Miyake¹, ¹Immunology, Juntendo University School of Medicine, Tokyo, Japan, ²Department of Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, ³Department of Rheumatology, Juntendo University School of Medicine, Tokyo, Japan, ⁴Internal Medicine and Rheumatology, Juntendo University School of Medicine, Tokyo, Japan
Background/Purpose: Mucosal-associated invariant T (MAIT) cells are innate-like lymphocytes that express a semi-invariant TCRα chain: Vα7.2-Jα33 in humans and Vα19-Jα33 in mice. MAIT cells are…
Abstract Number: 3170 • 2016 ACR/ARHP Annual Meeting
Association Between Insulin Resistance, Subclinical Artheriosclerosis and Activity/Damage Status in Systemic Lupus Erythematosus Patients
Hiurma Sanchez-Perez¹, Beatriz Tejera² and Ivan Ferraz-Amaro³, ¹Rheumatology, Rheumatology Division, Hospital Universitario de Canarias, La Laguna, Spain, ²Rheumatology Division, Hospital Universitario de Canarias, Santa Cruz de Tenerife, Spain, ³Rheumatology, Rheumatology Division, Hospital Universitario de Canarias, Tenerife, Spain
Background/Purpose: Insulin resistance (IR) may contribute to an increase in cardiovascular risk. The aim of this study was to examine the association between IR and…
Abstract Number: 487 • 2016 ACR/ARHP Annual Meeting
Limited Utility of Cytokine Profiles in Rheumatoid Arthritis Patients with Clinically Active Disease and Normal Inflammatory Indices
Gail S. Kerr¹, Asha Mariam Alex², Harlan Sayles³ and Ted R Mikuls⁴, ¹Washington DC VAMC, Georgetown University Hospital, Howard University Hospital, Washington, DC, ²Rheumatology, Georgetown University Hospital, Washington, DC, ³University of Nebraska Medical Center, Omaha, NE, ⁴Internal Medicine, Division of Rheumatology, University of Nebraska Medical Center, Omaha, NE

<span"><spanont-size: "="" "="" 3"="3" medium;"="medium;"> Background/Purpose: Multiple biomarker disease activity (MBDA) cytokine panels identify RA subsets with continuing inflammation despite fulfilling clinical and acute phase…
Abstract Number: 548 • 2016 ACR/ARHP Annual Meeting
Body Mass Index Is Positively Correlated with Diverse Disease Activity Measures in Longstanding Rheumatoid Arthritis
Craig Wiesenhutter, Coeur d'Alene Arthritis Clinic, Coeur D Alene, ID; University of Washington School of Family Medicine, Seattle, ID
Background/Purpose: Obesity is a common problem with patients who have rheumatoid arthritis (RA). Adipose tissue has been shown to produce cytokines that are proinflammatory. The…
Abstract Number: 620 • 2016 ACR/ARHP Annual Meeting
Clinical Activity, Ultrasound Assessment and Drug Monitoring in Rheumatoid Arthritis Patients Receiving Anti-TNF-α Therapy with Extended Interval of Administration
José Miguel Senabre-Gallego¹, José Rosas¹, Francisca Llinares-Tello², Mariana Marco-Mingot², Ana Pons¹, Xavier Barber³, Gregorio Santos-Soler¹, Esteban Salas-Heredia¹, Catalina Cano¹, Marisa Lorente⁴, Marina Sanchís³, Juan Molina², Mario García-Carrasco⁵ and AIRE-MB, ¹Rheumatology, Hospital Marina Baixa, Villajoyosa (Alicante), Spain, ²Laboratory, Hospital Marina Baixa, Villajoyosa (Alicante), Spain, ³CIO, Universidad Miguel Hernández, Elche, Spain, ⁴Rheumatology, Hospital Marina Baixa, Villajoyosa, Spain, ⁵Systemic Autoimmune Diseases Research Unit, HGR 36-CIBIOR Instituto Mexicano del Seguro Social, Puebla, Mexico
Background/Purpose: To assess clinical activity, ultrasound synovitis and drug levels in rheumatoid arthritis (RA) patients receiving anti-TNFα therapy with extended interval of administration (EIA). Methods:…
Abstract Number: 727 • 2016 ACR/ARHP Annual Meeting
Effects of Nsaids on Disease Activity in Ankylosing Spondylitis
Mark Hwang¹, Prabha Ranganathan², MinJae Lee³, Seth Eisen¹, Michael Ward⁴, Lianne S. Gensler⁵, Matthew A. Brown⁶, Johnathan Jia⁷, Amirali Tahanan³, Mohammad H. Rahbar³, Michael Weisman⁸ and John D. Reveille⁹, ¹Internal Medicine-Rheumatology, Washington University in Saint Louis, School of Medicine, Saint Louis, MO, ²Washington University in Saint Louis, School of Medicine, Saint Louis, MO, ³Biostatistics/Epidemiology/Research Design (BERD) Core | Center for Clinical and Translational Sciences, University of Texas-McGovern Medical School, Houston, TX, ⁴NIH/NIAMS, Bethesda, MD, ⁵Medicine/Rheumatology, UCSF, San Francisco, CA, ⁶University of Queensland Diamantina Institute, Brisbane, Australia, ⁷University of Texas-McGovern Medical School, Houston, TX, ⁸Rheumatology, Cedars-Sinai Medical Center, Los Angeles, CA, ⁹Rheumatology, University of Texas-McGovern Medical School, Houston, TX
Background/Purpose: NSAIDs are the first line pharmacologic therapy in ankylosing spondylitis (AS). Several NSAIDs are efficacious in AS without superiority demonstrated by any particular…
Abstract Number: 700 • 2015 ACR/ARHP Annual Meeting
Problems of Untranslatability: Example of Turkish Version of Basdai
Pamir Atagunduz¹, Elmar Mammadov², Ina Dervishi², Metin Beyatlı², Kubra Nur Salcı³, Nafisa Auwal Abdulhamid⁴, Gulsen Ozen⁵, Ali Ugur Unal¹, Zeynep Erturk¹, Nevsun Inanc⁵ and Haner Direskeneli⁵, ¹Rheumatology, Marmara University School of Medicine, Istanbul, Turkey, ²None, Marmara University School of Medicine, Istanbul, Turkey, ³Marmara University School of Medicine, istanbul, Turkey, ⁴Marmara University School of Medicine, Istanbul, Turkey, ⁵Department of Rheumatology, Marmara University Faculty of Medicine, Istanbul, Turkey
Background/Purpose: Translators of self-report forms commonly encounter problems related to untranslatability, a term used to describe words that cannot be meaningfully translated from one language…
Abstract Number: 708 • 2015 ACR/ARHP Annual Meeting
Development of an Activity Disease Score in Patients with Uveitis
Esperanza Pato Cour¹, Maria Auxiliadora Martin², Santiago MuÑoz Fernandez³, Adela Castello⁴, Fernando Sanchez-Alonso⁵, David Diaz-Valle⁶, Rosalía Mendez⁷ and Uveitis MeVa Group, ¹Rheumatology, Hospital Clínico San Carlos, Madrid, Spain, ²Research Unit of Spanish Society of Rheumatology,, Madrid, Spain, ³Rheumatology, Hospital Infanta Sofía, Madrid, Spain, ⁴Cancer Epidemiology Unit, National Center for Epidemiology, Instituto de Salud Carlos III, Madrid, Spain, Madrid, Spain, ⁵Unidad de Investigación, Spanish Society of Rheumatology, Madrid, Spain, ⁶Hospital Clínico San Carlos de Madrid, Madrid, Spain, ⁷Ophthalmology, Hospital Clínico San Carlos, Madrid, Spain

Background/Purpose: Uveitis is commonly defined as inflammation of the uvea, the vascular middle layer of the eye. Standardized and validated outcome measures are lacking in…
Abstract Number: 716 • 2015 ACR/ARHP Annual Meeting
Urinary Proteomics Identifies Three Novel Biomarkers for Lupus Nephritis Activity: Retinol Binding Protein, Alpha-1-Antichymotrysin and Haptoglobin
Amita Aggarwal¹, Sudhir sinha², Ranjan Gupta³, Liza Rajasekhar⁴, Akhilesh Yadav³, Ramnath Misra¹ and Virsingh Negi⁵, ¹Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, ²Department of Biochemistry, CSIR-central drug research institute, Lucknow, India, ³Department of Clinical Immunology, Sanjay Gandhi Postgraduate Institute of Medical Sciences, Lucknow, India, ⁴Department of Rheumatology, Nizam Institute of Medical Sciences, Hyderabad, India, ⁵Department of Clinical Immunology, JIPMER, Puducherry, India
Background/Purpose: Urinary biomarkers have a potential for identification, follow-up and assessment of response to treatment in patients with lupus nephritis. Urinary proteomics can help in…
Abstract Number: 745 • 2015 ACR/ARHP Annual Meeting
Changes in Serum Albumin Levels Correlate Highly with Severity and Activity of SLE
Bao Nguyen¹, Dawn Piarulli², Jennifer Johnson³ and David Horwitz^1,4, ¹Medicine, Keck School of Medicine of USC, Los Angeles, CA, ²Internal Medicine, Division of Rheumatology, Keck School of Medicine of USC, Los Angeles, CA, ³Medicine, Keck School of Medicine of USC, Los Angeles,, CA, ⁴Medicine-Rheumatology-Immun, Keck School of Medicine of USC, Los Angeles, CA
Background/Purpose: When a complex patient with long term lupus is seen for the first time, there is a need for a readily and commonly available…
Abstract Number: 753 • 2015 ACR/ARHP Annual Meeting
Serum Levels of Tenascin-C Discriminate Patients with Active SLE from Inactive Patients and Healthy Controls, and Predict the Need to Escalate Immunosuppressive Therapy
Jakub Zavada¹, Michal Uher², Radka Svobodova³, Marta Olejarova¹, Marketa Husakova³, Hana Ciferska³, Hana Hulejova⁴, Ladislav Senolt³ and Jiri Vencovsky³, ¹Institute of Rheumatology and Department of Rheumatology, 1st Faculty of Medicine, Charles University, Prague, Czech Republic, Prague, Czech Republic, ²Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech Republic, ³Institute of Rheumatology, Prague, Czech Republic, ⁴Institute of Rheumatology and Department of Rheumatology, Prague, Czech Republic
Background/Purpose: The aim of this study was to examine whether circulating levels of the pro-inflammatory glycoprotein tenascin-C (TSC) are useful as an activity-specific or predictive…
Abstract Number: 1658 • 2015 ACR/ARHP Annual Meeting
Rheumatoid Factor Status Affects the Efficacy of First Biological Treatment in RA
Yoshikazu Ogawa¹, Nobunori Takahashi², Koji Funahashi², Shuji Asai³, Toki Takemoto³, Tatsuo Watanabe³, Nobuyuki Asai², Naoki Ishiguro⁴ and Toshihisa Kojima², ¹orthopedic surgery, Nagoya University Hospital, Nagoya, Japan, ²Department of Orthopedic Surgery, Nagoya University Hospital, Nagoya, Japan, ³Nagoya University Hospital, Nagoya, Japan, ⁴Department of Orthopedic Suregery, Nagoya University Hospital, Nagoya, Japan

Background/Purpose: Rheumatoid factor (RF) is considered an important factor in diagnosing rheumatoid arthritis (RA). The association between the treatment efficacy of biological agents and RF…
Abstract Number: 2545 • 2015 ACR/ARHP Annual Meeting
Psychometric Testing of the Valued Life Activities Questionnaire in People with Rheumatoid Arthritis in the UK: Rasch Analysis
Yeliz Prior¹, Alan Tennant² and Alison Hammond³, ¹Centre for Health Sciences, University of Salford, Greater Manchester, United Kingdom, ²Human Functioning Sciences, ICF Unit, Swiss Paraplegic Research, Nottwil, Switzerland, ³Centre for Health Sport & Rehabilitation Research, University of Salford, Salford, United Kingdom
Background/Purpose: Developed in the USA, the Valued Life Activities Scale (VLAs) measures participation in daily activities. We have linguistically and culturally adopted the VLAs 33…
Abstract Number: 2659 • 2015 ACR/ARHP Annual Meeting
Poor Correlation Between Vectra DA and DAS28 Scores in Patients with Rheumatoid Arthritis
Marcia S. Genta¹, Amnon Sonnenberg² and Robert M. Genta³, ¹Dallas Arthritis Center, Dallas, TX, ²Medicine - Gastroenterology, Portland VAMC - Oregon Health & Science University, Portland, OR, ³Laboratory, Dallas Arthritis Center, Dallas, TX

Background/Purpose: Vectra DA, a blood test that integrates the blood levels of 12 biomarkers into a single score (1-100), is claimed to provide an objective…

All abstracts accepted to PRYSM are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 6:00 PM CT on March 18. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].